PROphylaxis for vulnerable paTiEnts at risk of COVID-19 infecTion (PROTECT-V): A basket trial of prophylactic interventions in multiple at-risk patient groups
- Funded by LifeArc
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
LifeArcPrincipal Investigator
N/A
Research Location
United KingdomLead Research Institution
University of CambridgeResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
A trial investigating the efficacy of Niclosamide as a preventative drug against COVID-19 infection in vulnerable patient groups including patients on dialysis, patients with vasculitis and transplant patients. This a basket trial design allowing for the addition of further interventions and patient groups at later time points. Where possible appointments and testing will be carried out remotely to avoid any undue risk to patients.